Controlling High Blood Pressure: An Evidence-Based Blueprint for Change

Am J Med Qual. 2022 Jan-Feb;37(1):22-31. doi: 10.1097/01.JMQ.0000749856.90491.43.

Abstract

Recently published national data demonstrate inadequate and worsening control of high blood pressure (HBP) in the United States, outcomes that likely have been made even worse by the coronavirus disease 2019 (COVID-19) pandemic. This major public health crisis exposes shortcomings of the US health care delivery system and creates an urgent opportunity to reduce mortality, major cardiovascular events, and costs for 115 million Americans. Ending this crisis will require a more coherent and systemic change to traditional patterns of care. The authors present an evidence-based Blueprint for Change for comprehensive health delivery system redesign based on current national clinical practice guidelines and quality measures. This innovative model includes a systems-based approach to ensuring proper BP measurement, assessment of cardiovascular risk, effective patient-centered team-based care, addressing social determinants of health, and shared decision-making. The authors also propose building on current national quality improvement initiatives designed to better control HBP.

MeSH terms

  • COVID-19*
  • Humans
  • Hypertension* / prevention & control
  • Pandemics
  • Patient-Centered Care
  • SARS-CoV-2
  • United States